The purpose of this study is to determine whether plant sterols esterified to fish oil fatty acids in a fish oil matrix improve the lipid profile, predominantly LDL-cholesterol and TG concentrations in healthy hyperlipidemic subjects.
Phytosterols and omega-3 fatty acids (n-3) are natural food ingredients with potential cardiovascular (CVD) benefits. Phytosterols inhibit dietary cholesterol absorption and biliary cholesterol re-absorption, thereby reducing blood cholesterol levels, while consumption of n-3 is associated with a significant reduction in plasma triglyceride concentrations. Furthermore, n-3 may also beneficially modify a number of other risk factors of CHD, like anti-inflammatory and anti-thrombotic. The primary objective of this study is to determine whether plant sterols esterified to fish oil fatty acids in a fish oil matrix improve the lipid profile, predominantly LDL-cholesterol and TG concentrations in healthy hyperlipidemic subjects. In addition the supplement efficacy to lower other CVD-related risk factors of healthy will be evaluated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
91
1.6g phytosterols and 1.3g omega-3 fatty acids per day
4 gr of corn oil
Sheba medical center
Tel Litwinsky, Israel
LDL Cholesterol
Average of blood test results at -10 and 0 days (before and after run-in period)
Time frame: at baseline
LDL-C
Blood test results following 12 weeks of intervention
Time frame: 12 weeks
Triglycerides
Average of blood test results at -10 and 0 weeks (before and after run-in period)
Time frame: at baseline
Triglycerides
Blood test results following 12 weeks of intervention
Time frame: 12 weeks
Total Cholesterol
Average of blood test results at -10 and 0 weeks (before and after run-in period)
Time frame: at baseline
Total Cholesterol
Blood test results following 12 weeks of intervention
Time frame: 12 weeks
HDL Cholesterol
Average of blood test results at -10 and 0 weeks (before and after run-in period)
Time frame: at baseline
HDL-cholestrol
Blood test results following 12 weeks of intervention
Time frame: 12 weeks
CRP
Blood test results on day 0 of High sensitivity C Reactive Protein
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: at baseline
CRP
Blood test results following 12 weeks of intervention of High sensetivity C reactive protein
Time frame: 12 weeks
Apolipoprotein B100
Blood test results on day 0
Time frame: at baseline
Apolipoprotein B100
Blood test results follwing 12 weeks of intervention
Time frame: 12 weeks
Apolipoprotein A
Blood test on day 0
Time frame: at baseline
Apolipoprotein A
Blood test results following 12 weeks of intervention
Time frame: 12 weeks